Anavex Life Sciences Corp (AVXL): The latest patent application for ANAVEX...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	139
Posts	23734
Boards Moderated	0
Alias Born	04/08/2004

georgejjl

Re: None

Sunday, 02/10/2019 10:27:45 AM

Sunday, February 10, 2019 10:27:45 AM

The latest patent application for ANAVEX

NEURODEVELOPMENTAL DISORDER THERAPY

Abstract
This invention addresses tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73, AV2-73, or A2-73) in a method of treatment for neurodevelopmental disorders. Particular reference is made to the treatment of autism spectrum disorder, cerebral palsy, Rett syndrome, Angelman syndrome, Williams syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), childhood disintegrative disorder, and Smith-Magenis syndrome. Additional reference is made to multiple sclerosis.

Inventors: Missling; Christopher U.; (New York, NY)
Applicant:
Name City State Country Type

Anavex Life Science Corp.
New York
NY
US
Family ID: 57966177
Appl. No.: 16/068703
Filed: January 24, 2017
PCT Filed: January 24, 2017
PCT NO: PCT/US2017/014702
371 Date: July 9, 2018

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220190022052%22.PGNR.&OS=DN/20190022052&RS=DN/20190022052

Good luck and GOD bless,